Genmab A/S (ADR)

General ticker "GMAB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $14.5B (TTM average)

Genmab A/S (ADR) follows the US Stock Market performance with the rate: 53.3%.

Estimated limits based on current volatility of 1.1%: low 31.56$, high 32.28$

Factors to consider:

  • Total employees count: 548 as of 2019
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [18.64$, 31.44$]
  • 2025-12-31 to 2026-12-31 estimated range: [20.74$, 34.24$]

Financial Metrics affecting the GMAB estimates:

  • Positive: with PPE of 16.6 at the end of fiscal year the price was neutral
  • Positive: Operating profit margin, % of 31.14 > 18.64
  • Negative: negative Industry operating cash flow (median)
  • Negative: 0.01 < Interest expense per share per price, % of 0.13
  • Positive: -14.38 < Investing cash flow per share per price, % of -10.41
  • Negative: Industry earnings per price (median), % of -16.34 <= 0
  • Positive: Return on assets ratio (scaled to [-100,100]) of 14.62 > 6.04
  • Positive: 6.82 < Operating cash flow per share per price, % of 8.17

Similar symbols

Short-term GMAB quotes

Long-term GMAB plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue DKK14,505.00MM DKK16,474.00MM DKK21,526.00MM
Operating Expenses DKK8,238.00MM DKK11,153.00MM DKK14,823.00MM
Operating Income DKK6,267.00MM DKK5,321.00MM DKK6,703.00MM
Non-Operating Income DKK678.00MM DKK316.00MM DKK2,461.00MM
Interest Expense DKK21.00MM DKK27.00MM DKK120.00MM
R&D Expense DKK5,562.00MM DKK7,630.00MM DKK9,748.00MM
Income(Loss) DKK6,945.00MM DKK5,637.00MM DKK9,164.00MM
Taxes DKK1,493.00MM DKK0.00MM DKK1,320.00MM
Profit(Loss)* DKK3,869.00MM DKK4,352.00MM DKK7,844.00MM
Stockholders Equity DKK27,282.00MM DKK31,610.00MM DKK36,697.00MM
Inventory DKK0.00MM DKK57.00MM DKK62.00MM
Assets DKK30,119.00MM DKK35,289.00MM DKK45,811.00MM
Operating Cash Flow DKK3,912.00MM DKK7,380.00MM DKK7,771.00MM
Capital expenditure DKK317.00MM DKK376.00MM DKK187.00MM
Investing Cash Flow DKK-2,761.00MM DKK-1,282.00MM DKK-9,907.00MM
Financing Cash Flow DKK-789.00MM DKK-606.00MM DKK-3,919.00MM
Earnings Per Share** DKK5.92 DKK6.60 DKK12.14
Ordinary share to ADR 10.00x 10.00x 10.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.